Physician profile
Michael D Hellman
NPI 1114214970
$365,022.81
in general payments reported to CMS, 2019-2025
12 companies · $89K in 2025
The $89K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $1,526 · 2021: $28K · 2022: $76K · 2023: $80K · 2024: $90K · 2025: $89K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $230K · Travel and Lodging: $21K · Food and Beverage: $7,546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $230,312.77 |
| Travel and Lodging | $21,217.78 |
| Food and Beverage | $7,546.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $343,356.15 | 2019-2025 | Gmk Sphere, Amistem, Quadra |
| Zimmer Biomet Holdings, INC. | $17,339.80 | 2019-2025 | Rosa, Persona |
| Stryker Corporation | $1,562.01 | 2019-2025 | Mako, Insignia, Gamma |
| Microport Orthopedics INC | $1,470.44 | 2022 | |
| Davol INC. | $706.68 | 2022-2025 | Arista Ah Flexitip, Arista |
| Depuy Synthes Sales INC. | $167.86 | 2019-2023 | Peak, Monovisc, Orthovisc |
| Becton, Dickinson and Company | $163.83 | 2022 | |
| Radius Health, INC. | $138.46 | 2020 | |
| Medical Device Business Services, INC. | $47.46 | 2025 | Velys |
| Aesculap Implant Systems, LLC | $27.06 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $23.73 | 2025 | |
| Ethicon US, LLC | $19.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hellman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.